Treatment of ranula with intracystic injection of the Streptococcal preparation OK-432

Annals of Otology, Rhinology and Laryngology

Volumn 112, Issue 3, 2003, Pages 214-220

  Fukase, Shigeru ^a,b   Ohta, Nobuo ^a   Inamura, Kazutoshi ^a   Aoyagi, Masaru ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b Yamagata Prefectural Central Hospital   (Japan)

Author keywords

Intracystic injection; Lymphangioma; OK 432; Ranula

Indexed keywords

PICIBANIL;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CYSTIC LYMPHANGIOMA; DRUG CHOICE; FEMALE; FEVER; HOSPITAL CARE; HUMAN; INJECTION PAIN; INJECTION SITE; LYMPHANGIOMA; MALE; MOUTH; MUCOCELE; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROBLEM SOLVING; SAFETY; SCAR FORMATION; TREATMENT OUTCOME; INTRALESIONAL DRUG ADMINISTRATION; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MIDDLE AGED; PICIBANIL; RANULA;

EID: 0037332380     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940311200304     Document Type: Article

References (19)

1. Okamoto H, Minami M, Shoin S, Koshimura S, Shimizu R. Experimental anticancer studies. XXXI. On the streptococcal preparation having potent anticancer activity. Jpn J Exp Med 1966;36:175-86.
2. Watabe S, Sendo F, Kimura S, Arai S. Activation of cytotoxic polymorphonuclear leukocytes by in vivo administration of a streptococcal preparation, OK-432. J Natl Cancer Inst 1984;72:1365-70.
3. Fukase Y, Fukase S, Sendo F. Priming activity for chemiluminescence reaction of PMN in the culture supernatant of streptococcal preparation (OK-432)-stimulated spleen cells. Microbiol Immunol 1988;32:621-33.
4. Kitsuki H, Katano M, Ikubo A, et al. Induction of inflammatory cytokines in effusion cavity by OK-432 injection therapy for patients with malignant effusion: role of interferon-γ in enhancement of surface expression of ICAM-1 on tumor cells in vivo. Clin Immunol Immunopathol 1996;78:283-90.
5. Torisu M, Katano M, Kimura Y, Itoh H, Takesue M. New approach to management of malignant ascites by a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival. Surgery 1983;93:357-64.
6. Tsuchiya I, Kasahara T, Yamashita K, et al. Induction of inflammatory cytokines in the pleural effusion of cancer patients after the administration of an immunomodulator, OK-432: role of IL-8 for neutrophil infiltration. Cytokine 1993;5:595-603.
7. Ogita S, Tsuto T, Tokiwa K, Takahashi T. Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children. Br J Surg 1987;74:690-1.
8. Ogita S, Tsuto T, Tokiwa K, Takahashi T. Treatment of cystic hygroma in children with special reference to OK-432 therapy. Z Kinderchir 1987;42:297-81.
9. Ogita S, Tsuto T, Deguchi E, Tokiwa K, Yanagihara J, Iwai N. Treatment of lymphangiomas arising around cervicofacial region: surgery, bleomycin therapy and OK-432 therapy [in Japanese]. Nippon Geka Gakkai Zasshi 1989;90:1389-91.
10. Nagashima K, Ikeda H, Okumura Y, Kurashige K, Harasawa N, Nagamati Y. An evaluation of the therapeutic results of intralesional therapy and surgery for lymphangiomas in children [in Japanese]. Jpn J Pediatr Surg 1993;25:397-401.
11. Sung MW, Lee DW, Kim DY, et al. Sclerotherapy with Picibanil (OK-432) for congenital lymphatic malformation in the head and neck. Laryngoscope 2001;111:1430-3.
12. Hase T, Kodama M, Sano H, et al. Successful treatment of a recurrent large cystic hygroma in a child with intracystic injection of OK-432. Eur J Pediatr 1996;155:424.
13. Smith RJH, Burke DK, Sato Y, Poust IR, Kimura K, Bauman NM. OK-432 therapy for lymphangiomas. Arch Otolaryngol Head Neck Surg 1996;122:1195-9.
14. Watari H, Yamada H, Fujino T, et al. A case of intrauterine medical treatment for cystic hygroma. Eur J Obstet Gynecol Reprod Biol 1996;70:201-3.
15. Crysdale WS, Mendelsohn JD, Conley S. Ranulas - mucoceles of the oral cavity: experience in 26 children. Laryngoscope 1988;98:296-8.
16. Ikarashi T, Inamura K, Kimura Y. Cystic lymphangioma and plunging ranula treated by OK-432 therapy: a report of two cases. Acta Otolaryngol Suppl (Stockh) 1994(suppl 511):196-9.
17. Ogita S, Tsuto T, Nakamura K, Deguchi E, Iwai N. OK-432 therapy for cystic hygroma and cavernous lymphangioma [in Japanese]. Jpn J Pediatr Surg 1993;25:371-6.
18. Tsuchibayashi Y, Ogita S. Histopathological study of the effect of OK-432 on lymphangioma of an infant. J Kyoto Pref Univ Med 1993;102:1055-60.
19. Ogita S, Tsuto T, Nakamura K, Deguchi E, Tokiwa K, Iwai N. OK-432 therapy for lymphangioma in children: why and how does it work? J Pediatr Surg 1996;31:477-80.